Pretreatment with interleukin-33 reduces warm hepatic ischemia/ reperfusion injury in mice

Chinese Medical Journal

Volumn 126, Issue 10, 2013, Pages 1855-1859

  Li, Shu ^a   Zhu, Feng Xue ^a   Zhang, Hong Bin ^a   Li, Hui ^a   An, You Zhong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Interleukin 33; Ischemia reperfusion; Liver; T helper lymphocyte

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTI-ST2L ANTIBODY; ANTIBODY; ASPARTATE AMINOTRANSFERASE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; LIVER ENZYME; MESSENGER RNA; PLASMA PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DISEASE SEVERITY; HELPER CELL; LAPAROTOMY; LIVER HISTOLOGY; LIVER ISCHEMIA; MALE; MOUSE; NONHUMAN; PATHOLOGY; PROTEIN EXPRESSION; REPERFUSION INJURY; TRANSMISSION ELECTRON MICROSCOPY; VASCULARIZATION;

ANIMALS; HUMANS; INTERLEUKINS; LIVER; MALE; MICE; MICE, INBRED BALB C; REPERFUSION INJURY;

EID: 84877850444     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20123530     Document Type: Article

References (20)

1. Kuboki S, Shin T, Huber N, Eismann T, Galloway E, Schuster R, et al. Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice. Hepatology 2008; 48: 1213-1223.
2. Li T, Zhao JM, Zhang Y, Pai ZL, Zhang W, Tuxun TH, et al. Suppression of acute rejective response following orthotopic liver transplantation in experimental rats infected with Echinococcus multilocularis. Chin Med J 2011; 124: 2818-2823.
3. Li Y, Liu NF, Gu ZZ, Chen Y, Lu J, Feng Y, et al. Coronary tortuosity is associated with reversible myocardial perfusion defects in patients without coronary artery disease. Chin Med J 2012; 125: 3581-3583.
4. Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant. 2011; 11: 1563-1569.
5. Mao J, Zhang L, Song AL, Chen X, Zhang YC. Effect of ulinastatin donor-pretreatment on liver graft during cold preservation in rats. Chin Med J 2011; 124: 574-580.
6. Caldwell CC, Tschoep J, Lentsch AB. Lymphocyte function during hepatic ischemia/reperfusion injury. J Leukoc Biol 2007; 82: 457-464.
7. Cao Z, Yuan Y, Jeyabalan G, Du Q, Tsung A, Geller DA, et al. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor. Am J Physiol Gastrointest Liver Physiol 2009; 297: G249-G258.
8. Kato A, Okaya T, Lentsch AB. Endogenous IL-13 protects hepatocytes and vascular endothelial cells during ischemia/ reperfusion injury. Hepatology 2003; 37: 304-312.
9. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-490.
10. Clarke C, Kuboki S, Sakai N, Kasten KR, Tevar AD, Schuster R, et al. CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury. Hepatology 2011; 53: 261-271.
11. Marvie P, Lisbonne M, L'helgoualc'h A, Rauch M, Turlin B, Preisser L, et al. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med 2010; 14: 1726-1739.
12. Arshad MI, Rauch M, L'Helgoualc'h A, Julia V, Leite-de- Moraes MC, Lucas-Clerc C, et al. NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis. Eur J Immunol 2011; 41: 2341-2348.
13. Sakai N, Van Sweringen HL, Quillin RC, Schuster R, Blanchard J, Burns JM, et al. Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice. Hepatology 2012; 56: 1468-1478.
14. Yin H, Huang BJ, Yang H, Huang YF, Xiong P, Zheng F, et al. Pretreatment with soluble ST2 reduces warm hepatic ischemia/ reperfusion injury. Biochem Biophys Res Commun 2006; 351: 940-946.
15. Yin H, Li XY, Jin XB, Zhang BB, Gong Q, Yang H, et al. IL-33 prolongs murine cardiac allograft survival through induction of TH2-type immune deviation. Transplantation 2010; 89: 1189-1197.
16. Alves-Filho JC, Sônego F, Souto FO, Freitas A, Verri WA Jr, Auxiliadora-Martins M, et al. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 2010; 16: 708-712.
17. Hazlett LD, McClellan SA, Barrett RP, Huang X, Zhang Y, Wu M, et al. IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 2010; 51: 1524-1532.
18. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000; 174: 5-20.
19. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF. CD4(+) T-lymphocytes mediate ischemia/ reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100: 279-289.
20. Oo YH, Adams DH. The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun 2010; 34: 45-54.